Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE® (trofinetide)
Pipeline
Pipeline
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Compassionate Use
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
2019
Older
Aug 30, 2017
Change of Director's Interest Notice
Aug 30, 2017
Change of Director's Interest Notice
Aug 30, 2017
Change of Director's Interest Notice
Aug 29, 2017
Notice under section 708A(5)(e) of the Corporations Act
Aug 29, 2017
Appendix 3B
Aug 29, 2017
Results of Meeting
Aug 24, 2017
Neuren reports 2017 half-year results
Aug 24, 2017
Half Yearly Report and Accounts
Aug 14, 2017
Notice of special meeting of shareholders
Jul 27, 2017
Appendix 4C - quarterly
Previous
1
2
3
4
5
Next
